CII
TEVA icon

Capital International Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Capital International Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,359
Closed -$248K – 341
2023
Q3 		$248K Sell
24,359
-82,763
-77% -$771K ﹤0.01% 324
2023
Q2 		$807K Sell
107,122
-209,884
-66% -$1.7M 0.01% 296
2023
Q1 		$2.81M Sell
317,006
-7,377
-2% -$72.9K 0.06% 197
2022
Q4 		$2.96M Buy
324,383
+28,634
+10% +$250K 0.06% 190
2022
Q3 		$2.39M Buy
295,749
+120,462
+69% +$1.07M 0.05% 211
2022
Q2 		$1.32M Buy
175,287
+9,890
+6% +$86.2K 0.02% 241
2022
Q1 		$1.55M Hold
165,397
– – 0.02% 250
2021
Q4 		$1.32M Sell
165,397
-10,060
-6% -$90.8K 0.01% 272
2021
Q3 		$1.71M Sell
175,457
-251,031
-59% -$2.35M 0.02% 262
2021
Q2 		$4.22M Sell
426,488
-144,233
-25% -$1.53M 0.04% 216
2021
Q1 		$6.59M Sell
570,721
-346,578
-38% -$3.97M 0.06% 193
2020
Q4 		$8.85M Buy
917,299
+154,019
+20% +$1.48M 0.08% 168
2020
Q3 		$6.88M Buy
763,280
+188,940
+33% +$2M 0.08% 162
2020
Q2 		$7.08M Buy
574,340
+390,777
+213% +$4.42M 0.09% 154
2020
Q1 		$1.65M Buy
+183,563
New +$1.88M 0.03% 182

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Capital International Inc's TEVA Position: Q4 2023 in Review

Capital International Inc sold out of Teva Pharmaceuticals (TEVA) in Q4 2023, closing a stake of 24,359 shares — an estimated $248K sold.

Capital International Inc first reported a position in TEVA in Q1 2020 and held it in 15 quarters. The position peaked at $8.85M in Q4 2020. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • Capital International Inc reported no remaining Teva Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Capital International Inc sold 24,359 Teva Pharmaceuticals shares in Q4 2023, an estimated $248K.
  • Capital International Inc first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 15 quarters.
  • Capital International Inc's Teva Pharmaceuticals position peaked at $8.85M in Q4 2020.
  • 447 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2023.

Based on Capital International Inc's 13F filing for Q4 2023, filed 13 Feb 2024.